Last 9,370 KRW
Change Today -120.00 / -1.26%
Volume 144.9K
As of 2:11 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

komipharm international co (041960) Snapshot

Open
9,400
Previous Close
9,490
Day High
9,600
Day Low
9,370
52 Week High
05/29/14 - 11,450
52 Week Low
11/26/13 - 6,730
Market Cap
474.6B
Average Volume 10 Days
431.9K
EPS TTM
-2.00
Shares Outstanding
50.7M
EX-Date
03/23/07
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KOMIPHARM INTERNATIONAL CO (041960)

Related News

No related news articles were found.

komipharm international co (041960) Related Businessweek News

No Related Businessweek News Found

komipharm international co (041960) Details

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals, and bio-fertilizers. It also provides laboratory test services, such as clinical diagnosis, examination, and assay. The company provides vaccines for swine, cattle, poultry, and canine; and chemicals, such as injectable antibiotics, antibacterial agents, multi-vitamin and essential amino acids injectable solution, and disinfectant for drinking water and live stock house. It also offers DF-100, a grape fruit seed extract used in various applications, such as beverages, noodles, cookies, cosmetics, and disinfectants, as well as foods made of meat, fish, and milk. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. Komipharm International Co., Ltd. was founded in 1972 and is headquartered in Siheung, South Korea.

Founded in 1972

komipharm international co (041960) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

komipharm international co (041960) Key Developments

Komipharm International Co., Ltd., Annual General Meeting, Mar 28, 2014

Komipharm International Co., Ltd., Annual General Meeting, Mar 28, 2014., at 10:00 Korea Standard Time. Location: 17 Place Gyeonggi Shiheung economy Co. headquarters conference room komipam. Agenda: To consider the approval of the financial statements and in the consolidated financial statements; to consider the appointment of standing auditor bakyigeun; to consider the approval of director remuneration; and to consider the approval of the remuneration.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
041960:KS 9,370.00 KRW -120.00

041960 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 041960.
View Industry Companies
 

Industry Analysis

041960

Industry Average

Valuation 041960 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 16.7x
Price/Book 10.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 15.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KOMIPHARM INTERNATIONAL CO, please visit www.komilab.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.